|
End-of-day quote
New Zealand S.E.
17/08/2026
|
5-day change | 1st Jan Change | ||
| 4.300 NZD | -2.27% |
|
-6.52% | +27.22% |
| 07-31 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 07-31 | New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire | MT |
| Market Cap | 451M 266M 230M 216M 197M 370M 25.47B 375M 2.53B 991M 12.76B 1B 979M 42.45B | P/E 2027 * |
22.9x | P/E 2028 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 481M 284M 245M 230M 210M 394M 27.16B 399M 2.7B 1.06B 13.61B 1.07B 1.04B 45.26B | EV / Sales 2027 * |
1.58x | EV / Sales 2028 * | 1.38x |
| Free-Float |
22.37% | Yield 2027 * |
0.76% | Yield 2028 * | 0.97% |
Last Transcript: AFT Pharmaceuticals Limited
| 20/01/24 | Rentevrees zet Bel20 onder druk | |
| 19/01/24 | KBC uitblinker op groene beurs | |
| 19/01/24 | Brusselse beurs opent flink hoger | |
| 19/01/24 | Brussel start handelsdag vermoedelijk in het groen | |
| 18/01/24 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | -2.27% | ||
| 1 week | -6.52% | ||
| Current month | -10.60% | ||
| 1 month | +9.97% | ||
| 3 months | +23.21% | ||
| 6 months | +19.44% | ||
| Current year | +27.22% |
| 1 week | 4.3 | 4.55 | |
| 1 month | 3.91 | 4.85 | |
| Current year | 3.35 | 4.85 | |
| 1 year | 2.56 | 4.85 | |
| 3 years | 2.37 | 4.85 | |
| 5 years | 2.37 | 5 | |
| 10 years | 1.7 | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 04/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 04/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 22/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 04/09/1997 |
Marree Atkinson
BRD | Director/Board Member | - | 04/09/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/07/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 26/06/25 | Free | Founder | 17,755 | 0.0169% | ||
| 02/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.27% | -6.52% | +67.97% | +22.51% | 272M | ||
| +0.25% | -3.96% | +68.73% | +120.06% | 1,052B | ||
| +0.78% | +0.21% | +48.53% | +50.78% | 627B | ||
| +0.35% | +0.95% | +21.11% | +66.86% | 441B | ||
| +0.28% | -4.56% | +39.10% | +38.05% | 349B | ||
| +0.78% | -2.68% | +24.03% | +37.32% | 287B | ||
| +0.87% | -3.59% | -0.28% | +7.12% | 241B | ||
| +1.00% | +0.52% | +41.46% | +58.95% | 224B | ||
| -0.78% | -4.49% | -10.28% | -54.13% | 202B | ||
| +0.40% | +4.40% | +17.36% | +81.59% | 172B | ||
| Average | +0.17% | -1.59% | +31.77% | +42.91% | 359.55B | |
| Weighted average by Cap. | +0.44% | -1.70% | +39.71% | +63.87% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 179M 155M 145M 132M 249M 17.16B 252M 1.7B 668M 8.6B 674M 659M 28.6B | 345M 204M 176M 165M 150M 283M 19.5B 287M 1.94B 759M 9.77B 766M 749M 32.5B |
| Net income | 19.7M 11.64M 10.05M 9.42M 8.58M 16.14M 1.11B 16.36M 110M 43.29M 557M 43.69M 42.74M 1.85B | 24.81M 14.66M 12.66M 11.87M 10.81M 20.33M 1.4B 20.62M 139M 54.54M 702M 55.04M 53.85M 2.34B |
| Net Debt | 29.84M 17.63M 15.22M 14.28M 13M 24.45M 1.69B 24.79M 167M 65.58M 844M 66.18M 64.75M 2.81B | 24.6M 14.53M 12.55M 11.77M 10.72M 20.16M 1.39B 20.44M 138M 54.07M 696M 54.56M 53.38M 2.32B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | NZ$4.300 | -2.27% | 8,824 |
| 14/08/26 | NZ$4.400 | -0.68% | 21,830 |
| 13/08/26 | NZ$4.430 | -1.99% | 3,377 |
| 12/08/26 | NZ$4.520 | -0.22% | 589 |
| 11/08/26 | NZ$4.530 | -1.52% | 11,298 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions

















